mizoribine has been researched along with Glomerulonephritis, Lupus in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (10.00) | 18.2507 |
| 2000's | 18 (45.00) | 29.6817 |
| 2010's | 18 (45.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okada, K; Takeuchi, T; Yagi, N; Yoshida, H | 1 |
| Hayashi, R; Hiromasa, T; Inoue, T; Kagawa, H; Sada, KE; Tsunashima, Y; Yamanaka, R | 1 |
| Amano, K; Chino, K; Ito, T; Kato, H; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Ogawa, H; Okuyama, A; Sakai, R; Shibata, A; Takei, H | 1 |
| Liu, J; Xing, CY; Zhang, M | 1 |
| Aizawa, T; Chiba, Y; Imaizumi, T; Matsumiya, T; Tanaka, H; Tsuruga, K; Watanabe, S; Yoshida, H | 1 |
| Aizawa, T; Imaizumi, T; Oki, E; Tanaka, H; Tsuruga, K; Watanabe, S | 1 |
| Chen, W; Da, Z; Feng, X; Gu, F; Liu, L; Liu, Y; Sun, L; Wei, H; Yin, S | 1 |
| Chan, TM | 1 |
| Clark, MR; Liarski, VM; Trotter, K | 1 |
| Kondo, Y; Matsukura, H; Matsunaga, A; Oki, E; Sato, N; Suzuki, J; Tanaka, H; Tsuruga, K | 1 |
| Ando, T; Hattori, S; Honda, M; Ikeda, M; Sasaki, S; Tanaka, Y; Yoshikawa, N | 1 |
| Kawasaki, Y | 1 |
| Kobayashi, D; Kuroda, T; Murakami, S; Nakano, M; Narita, I; Oyanagi, A; Sato, H; Wada, Y | 1 |
| Aizawa-Yashiro, T; Ito, Y; Kawasaki, Y; Oki, E; Sato, N; Suzuki, J; Tanaka, H; Tsuruga, K | 1 |
| Yumura, W | 1 |
| Hara, T; Hiromasa, T; Kagawa, H; Makino, H; Sada, KE; Takaki, A; Yamanaka, R | 1 |
| Amano, K; Ito, T; Kameda, H; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Ogawa, H; Okuyama, A; Sakai, R; Shirai, Y; Takei, H; Takeuchi, T | 1 |
| Aizawa-Yashiro, T; Echizenya, T; Ito, E; Tanaka, H; Tsuruga, K; Watanabe, S | 1 |
| Kishimoto, M; Nomura, A; Ohara, Y; Okada, M; Rokutanda, R; Shimizu, H; Suyama, Y; Yamaguchi, K | 1 |
| Abe, Y; Fuke, T; Hibino, S; Itabashi, K; Murayama, J; Nakano, Y; Saito, T; Sakurai, S; Takeshi, M; Watanabe, S | 1 |
| Ito, E; Nakahata, T; Sato, T; Suzuki, K; Tanaka, H | 1 |
| Ito, E; Nakahata, T; Suzuki, K; Tanaka, H; Tsugawa, K; Waga, S | 1 |
| Onda, H; Watanabe, T | 1 |
| Ito, E; Nakahata, T; Tanaka, H; Tsugawa, K; Tsuruga, K; Yumura, W | 1 |
| Abe, Y; Hisano, M; Iikura, Y; Miura, K; Nakada, M; Odajima, Y; Tsuji, Y; Watanabe, S | 1 |
| Ito, E; Nakahata, T; Suzuki, K; Tanaka, H; Tsugawa, K; Tsuruga, K; Waga, S | 1 |
| Iizuka, N; Kondo, H | 1 |
| Ito, E; Kudo, M; Nakahata, T; Suzuki, K; Tanaka, H; Tsugawa, K | 1 |
| Akashi, S; Fujinaga, S; Hira, M; Kaneko, K; Murakami, H; Ohtomo, Y; Takada, M; Yamashiro, Y | 1 |
| Koike, M; Moriyama, T; Naito, M; Nihei, H; Nitta, K; Otsubo, S; Suganuma, S; Takei, T; Uchida, K; Yumura, W | 1 |
| Akimoto, M; Aoki, N; Arima, N; Fujiwara, H; Hamada, H; Inoue, H; Kaieda, T; Matsushita, K; Ozaki, A; Satomura, A; Suruga, Y; Tei, C | 1 |
| Ito, E; Nakahata, T; Suzuki, K; Tanaka, H; Tsugawa, K | 1 |
| Ajiro, J; Gejyo, F; Hasegawa, H; Hirose, S; Ito, S; Kuroda, T; Murakami, S; Nakano, M; Nakatsue, T; Sakatsume, M; Sato, H; Tanabe, N; Wada, Y | 1 |
| Ito, E; Oki, ES; Suzuki, K; Tanaka, H; Tsugawa, K; Tsuruga, K | 1 |
| Ito, E; Oki, E; Suzuki, K; Tanaka, H; Tsugawa, K; Waga, S | 1 |
| Fukuda, W; Hamaguchi, M; Ishino, H; Kadoya, M; Kawahito, Y; Kohno, M; Niimi, M; Tsubouchi, Y; Wada, M; Yamamoto, A; Yoshikawa, T | 1 |
| Aihara, Y; Ibe, M; Kuriyama, T; Mitsuda, T; Mori, M; Shimizu, C; Takahashi, Y; Yokota, S | 1 |
| Ishikawa, H | 1 |
| Aihara, Y; Ibe, M; Imagawa, T; Ito, S; Katakura, S; Mitsuda, T; Miyamae, T; Mori, M; Nakasima, S; Tomono, N; Yokota, S | 1 |
| Emoto, Y; Maeda, K; Miyazaki, T; Naoe, T; Niwa, T; Yazawa, T | 1 |
6 review(s) available for mizoribine and Glomerulonephritis, Lupus
| Article | Year |
|---|---|
Treatment of severe lupus nephritis: the new horizon.
Topics: Antimalarials; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Nephritis; Mycophenolic Acid; Ribonucleosides; Severity of Illness Index; Sirolimus; Tacrolimus | 2015 |
Overview of pathophysiology and treatment of human lupus nephritis.
Topics: Abatacept; Antibodies, Monoclonal, Humanized; Autoantibodies; Biopsy; Cyclophosphamide; Dendritic Cells; Disease Progression; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammation; Interferon Type I; Kidney Failure, Chronic; Lupus Nephritis; Maintenance Chemotherapy; Mycophenolic Acid; Prognosis; Quinolones; Recombinant Fusion Proteins; Remission Induction; Ribonucleosides; Severity of Illness Index; T-Lymphocytes, Helper-Inducer; Treatment Outcome; Vimentin | 2016 |
Mizoribine: a new approach in the treatment of renal disease.
Topics: Adolescent; Adult; Child; Female; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Diseases; Lupus Nephritis; Middle Aged; Nephrotic Syndrome; Ribonucleosides; Treatment Outcome | 2009 |
[Secondary membranous nephropathy: The topics of membranous lupus nephritis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Calcineurin Inhibitors; Drug Therapy, Combination; Fluorouracil; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Lupus Nephritis; Mitomycin; Prognosis; Ribonucleosides; Semustine; Tacrolimus | 2011 |
[Mizoribine].
Topics: Animals; Arthritis, Rheumatoid; Depression, Chemical; Guanosine Monophosphate; Humans; Immunosuppressive Agents; Lupus Nephritis; Lymphocyte Activation; Mice; Purines; Randomized Controlled Trials as Topic; Ribonucleosides; Sjogren's Syndrome; T-Lymphocytes | 2005 |
Mizoribine and mycophenolate mofetil.
Topics: Animals; Arthritis; Carbon-Nitrogen Ligases; Cell Cycle; Cell Division; Clinical Trials as Topic; Creatine; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kinetics; Lupus Nephritis; Lymphocytes; Mice; Mitogens; Models, Biological; Models, Chemical; Mycophenolic Acid; Nephrotic Syndrome; Organ Transplantation; Ribonucleosides; Time Factors; Tumor Cells, Cultured | 1999 |
6 trial(s) available for mizoribine and Glomerulonephritis, Lupus
| Article | Year |
|---|---|
Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis.
Topics: Adolescent; Child; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Lupus Nephritis; Male; Pilot Projects; Prednisolone; Prospective Studies; Ribonucleosides; Tacrolimus; Treatment Outcome | 2014 |
Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Cyclophosphamide; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Ribonucleosides; Treatment Outcome; Young Adult | 2014 |
Combination therapy with steroids and mizoribine in juvenile SLE: a randomized controlled trial.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Age of Onset; Child; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Japan; Kaplan-Meier Estimate; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Prednisolone; Proteinuria; Pulse Therapy, Drug; Recurrence; Ribonucleosides; Time Factors; Treatment Outcome | 2010 |
Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis.
Topics: Administration, Oral; Adolescent; Adult; Child; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Pilot Projects; Prospective Studies; Ribonucleosides; Statistics, Nonparametric; Treatment Outcome | 2003 |
Mizoribine therapy for patients with lupus nephritis: the association between peak mizoribine concentration and clinical efficacy.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Lupus Nephritis; Middle Aged; Proteinuria; Ribonucleosides; Treatment Outcome | 2007 |
[Improvement of the maintenance therapy after methylprednisolone pulse therapy--effect of prednisolone combined with immunosuppressants].
Topics: Adolescent; Anti-Inflammatory Agents; Child; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methylprednisolone; Prednisolone; Pulse Therapy, Drug; Remission Induction; Ribonucleosides; Secondary Prevention | 1999 |
28 other study(ies) available for mizoribine and Glomerulonephritis, Lupus
| Article | Year |
|---|---|
Post-marketing surveillance study of the long-term use of mizoribine for the treatment of lupus nephritis: 2-Year results.
Topics: Adult; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Product Surveillance, Postmarketing; Ribonucleosides; Tacrolimus | 2018 |
The first year results of mizoribine/tacrolimus-based multitarget treatment for consecutive patients with lupus nephritis.
Topics: Adolescent; Adult; Aged; Cytomegalovirus Infections; Female; Humans; Lupus Nephritis; Male; Middle Aged; Ribonucleosides; Tacrolimus; Young Adult | 2018 |
Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide.
Topics: Adolescent; Antihypertensive Agents; Biphenyl Compounds; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Immunosuppressive Agents; Infusions, Intravenous; Irbesartan; Lupus Erythematosus, Systemic; Lupus Nephritis; Nephrotic Syndrome; Prednisolone; Pulse Therapy, Drug; Recurrence; Ribonucleosides; Severity of Illness Index; Tacrolimus; Tetrazoles | 2013 |
Study of the efficacy of mizoribine in lupus nephritis in Chinese patients.
Topics: Adolescent; Adult; Asian People; China; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Middle Aged; Prednisolone; Proteinuria; Remission Induction; Ribonucleosides; Treatment Outcome | 2013 |
Mizoribine selectively attenuates monocyte chemoattractant protein-1 production in cultured human glomerular mesangial cell: a possible benefit of its use in the treatment of lupus nephritis.
Topics: Cells, Cultured; Chemokine CCL2; Dexamethasone; Humans; IMP Dehydrogenase; Interleukin-8; Lupus Nephritis; Mesangial Cells; Poly I-C; Ribonucleosides | 2014 |
Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group.
Topics: Administration, Oral; Adolescent; Child; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Retrospective Studies; Ribonucleosides; Treatment Outcome; Young Adult | 2008 |
Mizoribine therapy in a patient with lupus nephritis: the association between mizoribine concentration and peritoneal dialysis.
Topics: Female; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Failure, Chronic; Lupus Nephritis; Peritoneal Dialysis; Ribonucleosides; Treatment Outcome; Young Adult | 2010 |
Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritis.
Topics: Adolescent; Biopsy; Cell Movement; Child; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Macrophages; Male; Renal Insufficiency; Ribonucleosides; Severity of Illness Index | 2010 |
Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Creatinine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Middle Aged; Pilot Projects; Prednisolone; Proteinuria; Remission Induction; Retrospective Studies; Ribonucleosides; Tacrolimus; Treatment Outcome | 2012 |
Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Pulse Therapy, Drug; Ribonucleosides; Severity of Illness Index; Treatment Outcome; Young Adult | 2013 |
Long-term multidrug therapy in an adolescent patient with proliferative lupus nephritis: a trial of less cytotoxic therapy.
Topics: Adolescent; Drug Therapy, Combination; Female; Humans; Lupus Nephritis; Prednisolone; Ribonucleosides; Tacrolimus | 2012 |
Efficacy and safety of multitarget therapy with mizoribine and tacrolimus for systemic lupus erythematosus with or without active nephritis.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Remission Induction; Retrospective Studies; Ribonucleosides; Tacrolimus; Time Factors; Treatment Outcome | 2012 |
Mizoribine requires individual dosing due to variation of bioavailability.
Topics: Adolescent; Biological Availability; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Retrospective Studies; Ribonucleosides; Treatment Outcome | 2012 |
Mizoribine oral pulse therapy for a patient with severe lupus nephritis.
Topics: Administration, Oral; Child; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Ribonucleosides; Severity of Illness Index | 2003 |
Hemichorea with antiphospholipid antibodies in a patient with lupus nephritis.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Brain; Child; Chorea; Functional Laterality; Humans; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Lupus Erythematosus, Systemic; Lupus Nephritis; Magnetic Resonance Imaging; Male; Ribonucleosides; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2004 |
Mizoribine pulse therapy for patients with flares of lupus nephritis: a 1-year observation.
Topics: Adolescent; Adult; Child; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Nephritis; Pulse Therapy, Drug; Ribonucleosides; Time Factors | 2004 |
Pharmacokinetic study of mizoribine in an adolescent with lupus nephritis.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Humans; Lupus Nephritis; Ribonucleosides | 2004 |
Mizoribine for the treatment of lupus nephritis in children and adolescents.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Prednisolone; Retrospective Studies; Ribonucleosides; Treatment Outcome | 2004 |
Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis.
Topics: Administration, Oral; Adolescent; Adult; Antibodies, Antinuclear; Child; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Disease Progression; DNA; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Prednisolone; Ribonucleosides; Severity of Illness Index; Treatment Outcome | 2005 |
Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.
Topics: Administration, Oral; Child; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney; Lupus Nephritis; Male; Methylprednisolone; Prednisolone; Remission Induction; Ribonucleosides; Severity of Illness Index | 2005 |
Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Lupus Nephritis; Middle Aged; Prednisolone; Ribonucleosides; Statistics, Nonparametric; Treatment Outcome | 2005 |
Stevens-Johnson syndrome induced by mizoribine in a patient with systemic lupus erythematosus.
Topics: Adult; Cyclophosphamide; Cyclosporine; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leukoencephalopathy, Progressive Multifocal; Lupus Nephritis; Prednisolone; Ribonucleosides; Stevens-Johnson Syndrome; Treatment Outcome | 2006 |
Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
Topics: Adolescent; Adult; Child; Female; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Lupus Nephritis; Ribonucleosides; Time Factors; Treatment Outcome | 2006 |
Long-term intermittent pulse therapy with mizoribine attenuates histologic progression in young patients with severe lupus nephritis: report of two patients.
Topics: Adolescent; Child; Disease Progression; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Pulse Therapy, Drug; Ribonucleosides; Severity of Illness Index; Time Factors | 2007 |
Long-term mizoribine intermittent pulse therapy, but not azathioprine therapy, attenuated histologic progression in a patient with severe lupus nephritis.
Topics: Adolescent; Azathioprine; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Pulse Therapy, Drug; Ribonucleosides; Treatment Outcome | 2007 |
A case of lupus nephritis improved after appropriately adjusting the dosage of mizoribine.
Topics: Adult; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Humans; Lupus Nephritis; Male; Nephrotic Syndrome; Prednisolone; Ribonucleosides | 2008 |
[Effects of combined administration of prednisolone and mizoribine in the course of remission for SLE children with nephritis].
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Female; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Prednisolone; Remission Induction; Ribonucleosides | 1994 |
A case of lupus nephritis showing rectal erosion with cytomegalovirus infection.
Topics: Adult; Cytomegalovirus Infections; Female; Humans; Lupus Nephritis; Prednisolone; Rectal Diseases; Ribonucleosides | 1991 |